Table of Content
1 Chronic Kidney Disease (CKD) Drug Market - Research Scope
1.1 Study Goals
1.2 Market Definition and Scope
1.3 Key Market Segments
1.4 Study and Forecasting Years
2 Chronic Kidney Disease (CKD) Drug Market - Research Methodology
2.1 Methodology
2.2 Research Data Source
2.2.1 Secondary Data
2.2.2 Primary Data
2.2.3 Market Size Estimation
2.2.4 Legal Disclaimer
3 Chronic Kidney Disease (CKD) Drug Market Forces
3.1 Global Chronic Kidney Disease (CKD) Drug Market Size
3.2 Top Impacting Factors (PESTEL Analysis)
3.2.1 Political Factors
3.2.2 Economic Factors
3.2.3 Social Factors
3.2.4 Technological Factors
3.2.5 Environmental Factors
3.2.6 Legal Factors
3.3 Industry Trend Analysis
3.4 Industry Trends Under COVID-19
3.4.1 Risk Assessment on COVID-19
3.4.2 Assessment of the Overall Impact of COVID-19 on the Industry
3.4.3 Pre COVID-19 and Post COVID-19 Market Scenario
3.5 Industry Risk Assessment
4 Chronic Kidney Disease (CKD) Drug Market - By Geography
4.1 Global Chronic Kidney Disease (CKD) Drug Market Value and Market Share by Regions
4.1.1 Global Chronic Kidney Disease (CKD) Drug Value ($) by Region (2015-2020)
4.1.2 Global Chronic Kidney Disease (CKD) Drug Value Market Share by Regions (2015-2020)
4.2 Global Chronic Kidney Disease (CKD) Drug Market Production and Market Share by Major Countries
4.2.1 Global Chronic Kidney Disease (CKD) Drug Production by Major Countries (2015-2020)
4.2.2 Global Chronic Kidney Disease (CKD) Drug Production Market Share by Major Countries (2015-2020)
4.3 Global Chronic Kidney Disease (CKD) Drug Market Consumption and Market Share by Regions
4.3.1 Global Chronic Kidney Disease (CKD) Drug Consumption by Regions (2015-2020)
4.3.2 Global Chronic Kidney Disease (CKD) Drug Consumption Market Share by Regions (2015-2020)
5 Chronic Kidney Disease (CKD) Drug Market - By Trade Statistics
5.1 Global Chronic Kidney Disease (CKD) Drug Export and Import
5.2 United States Chronic Kidney Disease (CKD) Drug Export and Import (2015-2020)
5.3 Europe Chronic Kidney Disease (CKD) Drug Export and Import (2015-2020)
5.4 China Chronic Kidney Disease (CKD) Drug Export and Import (2015-2020)
5.5 Japan Chronic Kidney Disease (CKD) Drug Export and Import (2015-2020)
5.6 India Chronic Kidney Disease (CKD) Drug Export and Import (2015-2020)
5.7 ...
6 Chronic Kidney Disease (CKD) Drug Market - By Type
6.1 Global Chronic Kidney Disease (CKD) Drug Production and Market Share by Types (2015-2020)
6.1.1 Global Chronic Kidney Disease (CKD) Drug Production by Types (2015-2020)
6.1.2 Global Chronic Kidney Disease (CKD) Drug Production Market Share by Types (2015-2020)
6.2 Global Chronic Kidney Disease (CKD) Drug Value and Market Share by Types (2015-2020)
6.2.1 Global Chronic Kidney Disease (CKD) Drug Value by Types (2015-2020)
6.2.2 Global Chronic Kidney Disease (CKD) Drug Value Market Share by Types (2015-2020)
6.3 Global Chronic Kidney Disease (CKD) Drug Production, Price and Growth Rate of ACE Inhibitors (2015-2020)
6.4 Global Chronic Kidney Disease (CKD) Drug Production, Price and Growth Rate of Angiotensin-II receptor blockers (2015-2020)
6.5 Global Chronic Kidney Disease (CKD) Drug Production, Price and Growth Rate of Calcium channel blockers (2015-2020)
6.6 Global Chronic Kidney Disease (CKD) Drug Production, Price and Growth Rate of Beta blockers (2015-2020)
6.7 Global Chronic Kidney Disease (CKD) Drug Production, Price and Growth Rate of Erythropoiesis-stimulating agents (ESAs) (2015-2020)
6.8 Global Chronic Kidney Disease (CKD) Drug Production, Price and Growth Rate of Diuretics (2015-2020)
6.9 Global Chronic Kidney Disease (CKD) Drug Production, Price and Growth Rate of Others (2015-2020)
7 Chronic Kidney Disease (CKD) Drug Market - By Application
7.1 Global Chronic Kidney Disease (CKD) Drug Consumption and Market Share by Applications (2015-2020)
7.1.1 Global Chronic Kidney Disease (CKD) Drug Consumption by Applications (2015-2020)
7.1.2 Global Chronic Kidney Disease (CKD) Drug Consumption Market Share by Applications (2015-2020)
7.2 Global Chronic Kidney Disease (CKD) Drug Consumption and Growth Rate of Hospitals (2015-2020)
7.3 Global Chronic Kidney Disease (CKD) Drug Consumption and Growth Rate of Specialty Clinics (2015-2020)
8 North America Chronic Kidney Disease (CKD) Drug Market
8.1 North America Chronic Kidney Disease (CKD) Drug Market Size
8.2 United States Chronic Kidney Disease (CKD) Drug Market Size
8.3 Canada Chronic Kidney Disease (CKD) Drug Market Size
8.4 Mexico Chronic Kidney Disease (CKD) Drug Market Size
8.5 The Influence of COVID-19 on North America Market
9 Europe Chronic Kidney Disease (CKD) Drug Market Analysis
9.1 Europe Chronic Kidney Disease (CKD) Drug Market Size
9.2 Germany Chronic Kidney Disease (CKD) Drug Market Size
9.3 United Kingdom Chronic Kidney Disease (CKD) Drug Market Size
9.4 France Chronic Kidney Disease (CKD) Drug Market Size
9.5 Italy Chronic Kidney Disease (CKD) Drug Market Size
9.6 Spain Chronic Kidney Disease (CKD) Drug Market Size
9.7 The Influence of COVID-19 on Europe Market
10 Asia-Pacific Chronic Kidney Disease (CKD) Drug Market Analysis
10.1 Asia-Pacific Chronic Kidney Disease (CKD) Drug Market Size
10.2 China Chronic Kidney Disease (CKD) Drug Market Size
10.3 Japan Chronic Kidney Disease (CKD) Drug Market Size
10.4 South Korea Chronic Kidney Disease (CKD) Drug Market Size
10.5 Southeast Asia Chronic Kidney Disease (CKD) Drug Market Size
10.6 India Chronic Kidney Disease (CKD) Drug Market Size
10.7 The Influence of COVID-19 on Asia Pacific Market
11 Middle East and Africa Chronic Kidney Disease (CKD) Drug Market Analysis
11.1 Middle East and Africa Chronic Kidney Disease (CKD) Drug Market Size
11.2 Saudi Arabia Chronic Kidney Disease (CKD) Drug Market Size
11.3 UAE Chronic Kidney Disease (CKD) Drug Market Size
11.4 South Africa Chronic Kidney Disease (CKD) Drug Market Size
11.5 The Influence of COVID-19 on Middle East and Africa Market
12 South America Chronic Kidney Disease (CKD) Drug Market Analysis
12.1 South America Chronic Kidney Disease (CKD) Drug Market Size
12.2 Brazil Chronic Kidney Disease (CKD) Drug Market Size
12.3 The Influence of COVID-19 on South America Market
13 Company Profiles
13.1 Johnson & Johnson
13.1.1 Johnson & Johnson Basic Information
13.1.2 Johnson & Johnson Product Profiles, Application and Specification
13.1.3 Johnson & Johnson Chronic Kidney Disease (CKD) Drug Market Performance (2015-2020)
13.2 F. Hoffmann-La Roche Ltd
13.2.1 F. Hoffmann-La Roche Ltd Basic Information
13.2.2 F. Hoffmann-La Roche Ltd Product Profiles, Application and Specification
13.2.3 F. Hoffmann-La Roche Ltd Chronic Kidney Disease (CKD) Drug Market Performance (2015-2020)
13.3 Amgen Inc.
13.3.1 Amgen Inc. Basic Information
13.3.2 Amgen Inc. Product Profiles, Application and Specification
13.3.3 Amgen Inc. Chronic Kidney Disease (CKD) Drug Market Performance (2015-2020)
13.4 Vifor Pharma Ltd
13.4.1 Vifor Pharma Ltd Basic Information
13.4.2 Vifor Pharma Ltd Product Profiles, Application and Specification
13.4.3 Vifor Pharma Ltd Chronic Kidney Disease (CKD) Drug Market Performance (2015-2020)
13.5 Keryx Biopharmaceuticals
13.5.1 Keryx Biopharmaceuticals Basic Information
13.5.2 Keryx Biopharmaceuticals Product Profiles, Application and Specification
13.5.3 Keryx Biopharmaceuticals Chronic Kidney Disease (CKD) Drug Market Performance (2015-2020)
13.6 Actavis PLC
13.6.1 Actavis PLC Basic Information
13.6.2 Actavis PLC Product Profiles, Application and Specification
13.6.3 Actavis PLC Chronic Kidney Disease (CKD) Drug Market Performance (2015-2020)
13.7 Raptor Pharmaceuticals
13.7.1 Raptor Pharmaceuticals Basic Information
13.7.2 Raptor Pharmaceuticals Product Profiles, Application and Specification
13.7.3 Raptor Pharmaceuticals Chronic Kidney Disease (CKD) Drug Market Performance (2015-2020)
13.8 Rockwell Medical
13.8.1 Rockwell Medical Basic Information
13.8.2 Rockwell Medical Product Profiles, Application and Specification
13.8.3 Rockwell Medical Chronic Kidney Disease (CKD) Drug Market Performance (2015-2020)
13.9 Shield Therapeutics
13.9.1 Shield Therapeutics Basic Information
13.9.2 Shield Therapeutics Product Profiles, Application and Specification
13.9.3 Shield Therapeutics Chronic Kidney Disease (CKD) Drug Market Performance (2015-2020)
13.10 OPKO Health
13.10.1 OPKO Health Basic Information
13.10.2 OPKO Health Product Profiles, Application and Specification
13.10.3 OPKO Health Chronic Kidney Disease (CKD) Drug Market Performance (2015-2020)
13.11 Abbott Laboratories
13.11.1 Abbott Laboratories Basic Information
13.11.2 Abbott Laboratories Product Profiles, Application and Specification
13.11.3 Abbott Laboratories Chronic Kidney Disease (CKD) Drug Market Performance (2015-2020)
13.12 Takeda Pharmaceuticals
13.12.1 Takeda Pharmaceuticals Basic Information
13.12.2 Takeda Pharmaceuticals Product Profiles, Application and Specification
13.12.3 Takeda Pharmaceuticals Chronic Kidney Disease (CKD) Drug Market Performance (2015-2020)
13.13 Cara Therapeutics
13.13.1 Cara Therapeutics Basic Information
13.13.2 Cara Therapeutics Product Profiles, Application and Specification
13.13.3 Cara Therapeutics Chronic Kidney Disease (CKD) Drug Market Performance (2015-2020)
13.14 FibroGen
13.14.1 FibroGen Basic Information
13.14.2 FibroGen Product Profiles, Application and Specification
13.14.3 FibroGen Chronic Kidney Disease (CKD) Drug Market Performance (2015-2020)
13.15 Regulus Therapeutics
13.15.1 Regulus Therapeutics Basic Information
13.15.2 Regulus Therapeutics Product Profiles, Application and Specification
13.15.3 Regulus Therapeutics Chronic Kidney Disease (CKD) Drug Market Performance (2015-2020)
13.16 Xenetic Biosciences
13.16.1 Xenetic Biosciences Basic Information
13.16.2 Xenetic Biosciences Product Profiles, Application and Specification
13.16.3 Xenetic Biosciences Chronic Kidney Disease (CKD) Drug Market Performance (2015-2020)
13.17 AMAG Pharmaceuticals
13.17.1 AMAG Pharmaceuticals Basic Information
13.17.2 AMAG Pharmaceuticals Product Profiles, Application and Specification
13.17.3 AMAG Pharmaceuticals Chronic Kidney Disease (CKD) Drug Market Performance (2015-2020)
13.18 ZS Pharma
13.18.1 ZS Pharma Basic Information
13.18.2 ZS Pharma Product Profiles, Application and Specification
13.18.3 ZS Pharma Chronic Kidney Disease (CKD) Drug Market Performance (2015-2020)
13.19 Reata Pharmaceuticals
13.19.1 Reata Pharmaceuticals Basic Information
13.19.2 Reata Pharmaceuticals Product Profiles, Application and Specification
13.19.3 Reata Pharmaceuticals Chronic Kidney Disease (CKD) Drug Market Performance (2015-2020)
13.20 Pharmacosmos
13.20.1 Pharmacosmos Basic Information
13.20.2 Pharmacosmos Product Profiles, Application and Specification
13.20.3 Pharmacosmos Chronic Kidney Disease (CKD) Drug Market Performance (2015-2020)
13.21 Akebia Therapeutics
13.21.1 Akebia Therapeutics Basic Information
13.21.2 Akebia Therapeutics Product Profiles, Application and Specification
13.21.3 Akebia Therapeutics Chronic Kidney Disease (CKD) Drug Market Performance (2015-2020)
13.22 Sanofi
13.22.1 Sanofi Basic Information
13.22.2 Sanofi Product Profiles, Application and Specification
13.22.3 Sanofi Chronic Kidney Disease (CKD) Drug Market Performance (2015-2020)
14 Market Forecast - By Regions
14.1 North America Chronic Kidney Disease (CKD) Drug Market Forecast (2020-2025)
14.2 Europe Chronic Kidney Disease (CKD) Drug Market Forecast (2020-2025)
14.3 Asia-Pacific Chronic Kidney Disease (CKD) Drug Market Forecast (2020-2025)
14.4 Middle East and Africa Chronic Kidney Disease (CKD) Drug Market Forecast (2020-2025)
14.5 South America Chronic Kidney Disease (CKD) Drug Market Forecast (2020-2025)
15 Market Forecast - By Type and Applications
15.1 Global Chronic Kidney Disease (CKD) Drug Market Forecast by Types (2020-2025)
15.1.1 Global Chronic Kidney Disease (CKD) Drug Market Forecast Production and Market Share by Types (2020-2025)
15.1.2 Global Chronic Kidney Disease (CKD) Drug Market Forecast Value and Market Share by Types (2020-2025)
15.2 Global Chronic Kidney Disease (CKD) Drug Market Forecast by Applications (2020-2025)
